Literature DB >> 7977369

Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele.

J P Faber1, W Poller, S Weidinger, M Kirchgesser, R Schwaab, F Bidlingmaier, K Olek.   

Abstract

We have investigated the molecular basis of 15 new alpha 1-antitrypsin (alpha 1AT) variants. Phenotyping by isoelectric focusing (IEF) was used as a screening method to detect alpha 1AT variants at the protein level. Genotyping was then performed by sequence analysis of all coding exons, exon-intron junctions, and the hepatocyte-specific promoter region including exon Ic. Three of these rare variants are alleles of clinical relevance, associated with undetectable or very low serum levels of alpha 1AT:the PI*Q0saarbruecken allele generated by a 1-bp C-nucleotide insertion within a stretch of seven cytosines spanning residues 360-362, resulting in a 3' frameshift and the acquisition of a stop codon at residue 376; a point mutation in the PI*Q0lisbon allele, resulting in a single amino acid substitution Thr68(ACC)-->Ile(ATC); and an in-frame trinucleotide deletion delta Phe51 (TTC) in the highly deficient PI*Mpalermo allele. The remaining 12 alleles are associated with normal alpha 1AT serum levels and are characterized by point mutations causing single amino acid substitutions in all but one case. This exception is a silent mutation, which does not affect the amino acid sequence. The limitation of IEF compared with DNA sequence analysis, for identification of new variants, their generation by mutagenesis, and the clinical relevance of the three deficiency alleles are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977369      PMCID: PMC1918455     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Reliable phenotyping of alpha-1-antitrypsin by hybrid isoelectric focusing in an ultranarrow immobilized pH gradient.

Authors:  S Weidinger
Journal:  Electrophoresis       Date:  1992-04       Impact factor: 3.535

2.  PiT: a new allele in the alpha 1-antitrypsin system.

Authors:  P Kühnl; W Spielmann
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

3.  The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA.

Authors:  D H Perlmutter; R M Kay; F S Cole; T H Rossing; D Van Thiel; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978.

Authors:  D W Cox; A M Johnson; M K Fagerhol
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

5.  Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

Authors:  C Larsson
Journal:  Acta Med Scand       Date:  1978

6.  Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.

Authors:  G L Long; T Chandra; S L Woo; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

7.  DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z.

Authors:  D W Cox; S L Woo; T Mansfield
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

8.  The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease.

Authors:  J P Faber; W Poller; K Olek; U Baumann; J Carlson; B Lindmark; S Eriksson
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

9.  Mechanisms of spontaneous and induced frameshift mutation in bacteriophage T4.

Authors:  G Streisinger; J Owen
Journal:  Genetics       Date:  1985-04       Impact factor: 4.562

10.  Frameshift mutagenesis by eucaryotic DNA polymerases in vitro.

Authors:  T A Kunkel
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

View more
  13 in total

1.  Alpha-1 Antitrypsin Deficiency: A Predisposing Factor for the Development of Pulmonary Langerhans Cell Histiocytosis.

Authors:  Paul R Ellis; Edward J Campbell; Alice M Turner; Robert A Stockley
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

Review 2.  Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Authors:  Joanna Wozniak; Tomasz Wandtke; Piotr Kopinski; Joanna Chorostowska-Wynimko
Journal:  Hum Gene Ther       Date:  2015-09-29       Impact factor: 5.695

3.  Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.

Authors:  Toshiyuki Amano; Satoshi Inoha; Chun-Ming Wu; Toshio Matsushima; Kiyonobu Ikezaki
Journal:  Childs Nerv Syst       Date:  2003-07-25       Impact factor: 1.475

Review 4.  Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Authors:  Jennifer A Dickens; David A Lomas
Journal:  Drug Des Devel Ther       Date:  2011-08-17       Impact factor: 4.162

5.  Identification of compound heterozygous mutation in a Korean patient with alpha 1-antitrypsin deficiency.

Authors:  Dae-Hyun Ko; Ho Eun Chang; Sang Hoon Song; Hoil Yoon; Kyoung Un Park; Junghan Song
Journal:  Korean J Lab Med       Date:  2011-10-03

6.  The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Authors:  Tomás P Carroll; Catherine A O'Connor; Olwen Floyd; Joseph McPartlin; Dermot P Kelleher; Geraldine O'Brien; Borislav D Dimitrov; Valerie B Morris; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2011-07-13

7.  Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.

Authors:  Gian Andri Thun; Medea Imboden; Ilaria Ferrarotti; Ashish Kumar; Ma'en Obeidat; Michele Zorzetto; Margot Haun; Ivan Curjuric; Alexessander Couto Alves; Victoria E Jackson; Eva Albrecht; Janina S Ried; Alexander Teumer; Lorna M Lopez; Jennifer E Huffman; Stefan Enroth; Yohan Bossé; Ke Hao; Wim Timens; Ulf Gyllensten; Ozren Polasek; James F Wilson; Igor Rudan; Caroline Hayward; Andrew J Sandford; Ian J Deary; Beate Koch; Eva Reischl; Holger Schulz; Jennie Hui; Alan L James; Thierry Rochat; Erich W Russi; Marjo-Riitta Jarvelin; David P Strachan; Ian P Hall; Martin D Tobin; Morten Dahl; Sune Fallgaard Nielsen; Børge G Nordestgaard; Florian Kronenberg; Maurizio Luisetti; Nicole M Probst-Hensch
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

8.  Identification and characterisation of eight novel SERPINA1 Null mutations.

Authors:  Ilaria Ferrarotti; Tomás P Carroll; Stefania Ottaviani; Anna M Fra; Geraldine O'Brien; Kevin Molloy; Luciano Corda; Daniela Medicina; David R Curran; Noel G McElvaney; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

9.  Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report.

Authors:  Sabri Denden; Michele Zorzetto; Fethi Amri; Jalel Knani; Stefania Ottaviani; Roberta Scabini; Marina Gorrini; Ilaria Ferrarotti; Ilaria Campo; Jemni Ben Chibani; Amel Haj Khelil; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2009-04-15       Impact factor: 4.123

10.  Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid.

Authors:  Beatriz Lara; Maria Teresa Martínez; Ignacio Blanco; Cristina Hernández-Moro; Eladio A Velasco; Ilaria Ferrarotti; Francisco Rodriguez-Frias; Laura Perez; Irene Vazquez; Javier Alonso; Manuel Posada; Beatriz Martínez-Delgado
Journal:  Respir Res       Date:  2014-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.